Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Gains from Investment Securities (2018 - 2025)

Health Catalyst filings provide 8 years of Gains from Investment Securities readings, the most recent being -$8.0 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to -$8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.7 million, a 488.06% decrease, with the full-year FY2025 number at -$7.1 million, down 330.15% from a year prior.
  • Gains from Investment Securities hit -$8.0 million in Q4 2025 for Health Catalyst, down from -$1.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $13.7 million in Q3 2021 to a low of -$13.7 million in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was -$1.9 million (2021), compared with a mean of -$1.2 million.
  • Biggest five-year swings in Gains from Investment Securities: surged 700.56% in 2021 and later crashed 490.72% in 2022.
  • Health Catalyst's Gains from Investment Securities stood at -$13.7 million in 2021, then surged by 64.58% to -$4.8 million in 2022, then surged by 142.03% to $2.0 million in 2023, then tumbled by 180.77% to -$1.6 million in 2024, then crashed by 388.06% to -$8.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$8.0 million (Q4 2025), -$1.6 million (Q3 2024), and $2.0 million (Q2 2023) per Business Quant data.